Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2024 Earnings Call Transcript February 27, 2025
Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.26.
Operator: Welcome to the Cardiff Oncology Fourth Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference call over to Kiki Patel of Gilman Group – I am sorry,...
